Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Sponsored byRep. Quigley, Mike [D-IL-5]IL· Introduced 6 avril 2026

Open on Congress.gov

103

Cosponsors

Actions

Amendments

Committees

—

Since introduced

Introduced

Committee

Passed Chamber

Passed Both

Enacted

Step 0 of 0

Latest action

Motion to reconsider laid on the table Agreed to without objection.

22 juillet 2026·1 day ago

Summary

Reported to House · Updated 16 juillet 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases.

The bill reauthorizes

grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials,
grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and
a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.

Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs.

Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Timeline

19 actions

Considered as unfinished business.
22 juillet 2026 · Floor
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
22 juillet 2026 · Floor
Motion to reconsider laid on the table Agreed to without objection.
22 juillet 2026 · Floor
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
22 juillet 2026 · Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 8205.
20 juillet 2026 · Floor
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
20 juillet 2026 · Floor
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
20 juillet 2026 · Floor
Considered under suspension of the rules.
20 juillet 2026 · Floor
Considered under suspension of the rules. (consideration: CR H4652-4654; text: CR H4653)
20 juillet 2026 · Floor
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.
20 juillet 2026 · Floor
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.
20 juillet 2026 · Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 8205.
20 juillet 2026 · Floor
Placed on the Union Calendar, Calendar No. 637.
9 juillet 2026 · Calendars
Placed on the Union Calendar, Calendar No. 637.
9 juillet 2026 · Calendars
Placed on the Union Calendar, Calendar No. 637.
9 juillet 2026 · Calendars
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
9 juillet 2026 · Committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
9 juillet 2026 · Committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
9 juillet 2026 · Committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
9 juillet 2026 · Committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
9 juillet 2026 · Committee

Sponsorship

103 cosponsors

Sponsor

Rep. Quigley, Mike [D-IL-5]IL

Cosponsors

Democrat3876%
Republican1224%

Democrat:Rep. Mejia, Analilia [D-NJ-11]NJ
Democrat:Rep. Budzinski, Nikki [D-IL-13]IL
Democrat:Rep. Conaway, Herbert C. [D-NJ-3]NJ
Democrat:Rep. Magaziner, Seth [D-RI-2]RI
Democrat:Rep. Himes, James A. [D-CT-4]CT
Democrat:Rep. Watson Coleman, Bonnie [D-NJ-12]NJ
Democrat:Rep. Kaptur, Marcy [D-OH-9]OH
Democrat:Rep. Peters, Scott H. [D-CA-50]CA
Democrat:Rep. Casten, Sean [D-IL-6]IL
Democrat:Rep. Hayes, Jahana [D-CT-5]CT
Democrat:Rep. Larson, John B. [D-CT-1]CT
Democrat:Rep. Riley, Josh [D-NY-19]NY
Democrat:Rep. Grijalva, Adelita S. [D-AZ-7]AZ
Democrat:Rep. Latimer, George [D-NY-16]NY
Democrat:Rep. Pingree, Chellie [D-ME-1]ME
Democrat:Rep. Davis, Donald G. [D-NC-1]NC
Democrat:Rep. Jackson, Jonathan L. [D-IL-1]IL
Democrat:Rep. Carter, Troy A. [D-LA-2]LA
Democrat:Rep. Stansbury, Melanie A. [D-NM-1]NM
Democrat:Rep. McBride, Sarah [D-DE-At Large]DE
Democrat:Rep. Adams, Alma S. [D-NC-12]NC
Democrat:Rep. Beatty, Joyce [D-OH-3]OH
Democrat:Rep. Suozzi, Thomas R. [D-NY-3]NY
Democrat:Rep. Scanlon, Mary Gay [D-PA-5]PA
Democrat:Rep. Ross, Deborah K. [D-NC-2]NC
Democrat:Rep. Landsman, Greg [D-OH-1]OH
Republican:Rep. Miller, Carol D. [R-WV-1]WV
Democrat:Rep. Sorensen, Eric [D-IL-17]IL
Republican:Rep. Guest, Michael [R-MS-3]MS
Democrat:Rep. Bynum, Janelle S. [D-OR-5]OR
Democrat:Rep. Vindman, Eugene Simon [D-VA-7]VA
Republican:Rep. Wittman, Robert J. [R-VA-1]VA
Republican:Rep. Carter, John R. [R-TX-31]TX
Democrat:Rep. Stanton, Greg [D-AZ-4]AZ
Democrat:Rep. Cleaver, Emanuel [D-MO-5]MO
Republican:Rep. Moore, Tim [R-NC-14]NC
Democrat:Rep. Gottheimer, Josh [D-NJ-5]NJ
Republican:Rep. Amodei, Mark E. [R-NV-2]NV
Republican:Rep. Letlow, Julia [R-LA-5]LA
Democrat:Rep. Kelly, Robin L. [D-IL-2]IL
Democrat:Rep. Bishop, Sanford D. [D-GA-2]GA
Republican:Rep. Rouzer, David [R-NC-7]NC
Republican:Rep. Womack, Steve [R-AR-3]AR
Democrat:Rep. Whitesides, George [D-CA-27]CA
Republican:Rep. LaHood, Darin [R-IL-16]IL
Republican:Rep. Diaz-Balart, Mario [R-FL-26]FL
Democrat:Rep. Kennedy, Timothy M. [D-NY-26]NY
Democrat:Rep. Correa, J. Luis [D-CA-46]CA
Democrat:Rep. DelBene, Suzan K. [D-WA-1]WA
Republican:Rep. Bice, Stephanie I. [R-OK-5]OK

View all on Congress.gov

Classification

Policy area

Health

Committees

Energy and Commerce Committee
House · Standing
- Referred To6 Apr 2026
- Markup By21 May 2026
- Reported By9 Jul 2026
- Health Subcommittee
  - Referred to6 Apr 2026
  - Markup by13 May 2026
  - Reported by13 May 2026

Reports

H. Rept. 119-733

Track Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 as it moves through Congress